Customized Specimen Collection Kits Provide Convenience, Accuracy and Promotion Ideal for Post-Marketing Studies
Rochester, NY, Sept. 22, 2008 – ACM-Pivotal <http://www.acm-pivotal.com/> , the global central laboratory that continually defines the customer-service standard with its flexible approach, is now offering its unique KitKaddySM and lab collection kits to pharmaceutical, biotech and contract research organizations (CROs) that want to promote their brand at the physician level. The environmentally-friendly diagnostic specimen kits have been designed as easy-to-use space savers that help standardize collection across sites and countries. Companies can provide their logo, colors and additional brand elements to be printed on the kits, which will be housed at investigator sites throughout a clinical trial.
ACM-Pivotal will be showcasing its KitKaddy and collection kits, along with its safety testing expertise, at the 11th Registries and Post Approval Studies Congress <http://www.acm-pivotal.com/Registries_contact.html> in Washington, DC Sept. 23-25. The conference agenda is aimed at post-approval studies for improved safety and risk assessment.
ACM-Pivotal has been shipping KitKaddy and lab collection kits to investigator sites globally since 2003 and has received positive response from both investigators and sponsors. Customer demand and increased post-marketing studies have prompted ACM-Pivotal to offer a white-labeled solution to help increase brand awareness of new drugs available on the market.
“Our KitKaddy and lab collection kits are now multipurpose. Not only are they ideal for large safety studies, they provide an additional avenue for sponsors to reinforce their brands to a key audience,” said Elena Logan, VP, Clinical Trials. “With the continued emphasis on post-marketing safety studies, we are pleased to have a solution that is very well aligned with these commitments.”
The KitKaddy is organized with 24 custom visit and protocol-specific laboratory supply trays with the capacity to support large safety studies. Designed specifically for each clinical trial, all the necessary draw supplies are included. ACM-Pivotal’s collection kits enable clinicians to easily adhere to the specimen collection portion of protocols. Furthermore, the kits are assembled in a facility using 100 percent wind energy and manufactured using paperboard that is 100 percent recyclable and made from a renewable resource. The high-quality kits are produced in an ISO 9002 certified facility.
For more information and photos, please visit http://www.acm-pivotal.com/news_KitKaddy_9_22_08.html
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.